In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...

For instance, in February 2024, Roche announced that the US Food and Drug Administration (FDA) approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema (DME), a ...

Planning ahead is the best medicine for a quick and healthy recovery from surgery. Learn about the causes and best treatment options for hair loss. Learn the presurgery tips that can help improve ...

The phase 1 study tested autogene cevumeran (BNT122, RO7198457), a therapeutic mRNA cancer vaccine developed and researched through a collaboration between BioNTech, an immunotherapy company, and ...

chief medical officer and head of Global Product Development for Genentech. The most common adverse reactions reported with Susvimo were conjunctival hemorrhage, conjunctival hyperemia ...

Now there is an alternative to eye injections with Genentech's Susvimo (ranibizumab), which continuously delivers medicine through a surgical implant. The implant contains a reservoir that needs to be ...

Patients who develop a full-thickness macular hole after retinal detachment repair surgery can often be treated with a second procedure. Full-thickness macular holes (FTMHs) following rhegmatogenous ...

A look at the current state of AI in diabetic eye disease and where the future may take us. Artificial intelligence (AI) and deep learning tools are now a part of many people’s daily lives, whether ...

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...

The combination of Topcon's NW500 and AEYE-DS achieved 100% imageability and high diagnostic accuracy, with 92% sensitivity and 90% specificity. Over 99% of participants were successfully imaged on ...